$1.04
0.099.46%
Pre-Market: 5:56 AM EDT
Comments
Loading...
Plus Therapeutics Stock Guidance | NASDAQ:PSTV | Benzinga
Plus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plus Therapeutics Inc (PSTV) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Plus Therapeutics (PSTV)?
There have been no specific sales or earnings guidance reported for Plus Therapeutics in recent months.
Browse guidance and forecast on all stocks.